GlassScriptPhysician profile
Stefania E Nolano
NPI 1942500020
$5,868.32
in general payments reported to CMS, 2019-2025
11 companies · $1,873 in 2025
The $1,873 reported for 2025 was more than what 81% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2022: $1,587 · 2023: $1,204 · 2024: $837 · 2025: $1,873.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,677 · Travel and Lodging: $1,236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,677.36 |
| Travel and Lodging | $1,236.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endomagnetics LTD | $1,876.38 | 2022-2024 | Magseed, Magtrace |
| Axogen | $1,683.54 | 2025 | |
| Medtronic, INC. | $565.24 | 2022-2023 | Ligasure |
| Dilon Technologies, INC. | $506.98 | 2023-2025 | Hemoblast Bellows |
| Kub Technologies INC. | $368.18 | 2022-2024 | |
| Biom'Up Sa | $367.79 | 2019 | |
| Elucent Medical | $201.85 | 2022 | |
| Myriad Genetic Laboratories, INC. | $115.11 | 2022 | |
| Hologic Sales and Service, LLC | $105.75 | 2024 | 3dimensions, 3dquorum, Localizer |
| Merck Sharp & Dohme LLC | $56.51 | 2024 | Lynparza, Keytruda |
| Leica Microsystems INC. | $20.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stefania Nolano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.